UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2005, ISBN 0471478148, 443
eBook
2015, ISBN 1482221349, xix, 530
Book
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 06/2010, Volume 333, Issue 3, pp. 788 - 796
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Erlotinib Hydrochloride | Testis - metabolism | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Quinazolines - pharmacokinetics | Male | Neoplasm Proteins - metabolism | Brain - metabolism | Tissue Distribution | Dantrolene - pharmacokinetics | ATP-Binding Cassette Transporters - genetics | Quinidine - pharmacokinetics | ATP-Binding Cassette Transporters - metabolism | Piperidines - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Xenobiotics - metabolism | Neoplasm Proteins - genetics | Protein Kinase Inhibitors - pharmacokinetics | Antimalarials - pharmacokinetics | Blood-Brain Barrier - drug effects | Flavonoids - pharmacokinetics | Mice, Knockout | Muscle Relaxants, Central - pharmacokinetics | Algorithms | Animals | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | ATP Binding Cassette Transporter, Sub-Family B | Mice | Kinetics | Mitoxantrone - pharmacokinetics
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 02/2019, Volume 363, Issue 6427, p. 600
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Bromodeoxyuridine - analogs & derivatives | Animals | Bacteroides thetaiotaomicron - enzymology | Biotransformation | Bromodeoxyuridine - pharmacokinetics | Gastrointestinal Microbiome | Germ-Free Life | Biological Availability | Bromodeoxyuridine - toxicity | Mice | Clonazepam - pharmacokinetics | Bacteroides thetaiotaomicron - genetics | Drug metabolism | Pharmacokinetics | Analysis | Drugs | Transformation | Animal models | Physiological effects | Toxicity | Health services | Microbiomes | Microorganisms | Microbiota | Absorption | Metabolites | Antidepressants | Intestine | Compartments | Animal tissues | Genetics | Biocompatibility | Oxidation | Intestinal microflora | Xenobiotics | Digestive tract | Food | Enzymes | Gnotobiotics | Effectiveness | Computer simulation | Digestive system | Exposure | Pharmacology | Bioavailability | Clonazepam | Metabolism | Conversion | Benzodiazepines | Organic chemistry | Computer applications | Nucleosides | In vivo methods and tests | Kinetics | Variation | Nucleoside analogs
Journal Article
Environmental health perspectives, ISSN 0091-6765, 4/2011, Volume 119, Issue 4, pp. 422 - 430
Business publications audits | Reviews | Bisphenols | Rodents | Oral administration | Administered dose | Adults | Mice | Dosage | Female animals | Human resources | Endocrine disruption | Bisphenol A | Xenobiotic metabolism | Biomonitoring | Pharmacokinetics | Public, Environmental & Occupational Health | Environmental Sciences & Ecology | Toxicology | Life Sciences & Biomedicine | Science & Technology | Environmental Sciences | Public health. Hygiene-occupational medicine | Public health. Hygiene | Various organic compounds | Environment. Living conditions | Biological and medical sciences | Medical sciences | Chemical and industrial products toxicology. Toxic occupational diseases | Endocrine Disruptors - metabolism | Benzhydryl Compounds | Species Specificity | Humans | Liver - metabolism | Endocrine Disruptors - blood | Macaca mulatta | Environmental Exposure - analysis | Environmental Pollutants - metabolism | Phenols - metabolism | Environmental Pollutants - blood | Animals | Phenols - blood | Environmental Exposure - statistics & numerical data | Usage | Bisphenol-A | Primates | Physiological aspects | Research | Health aspects | Biological monitoring | Human | Cadmium | Monkeys | Females | Serums | Index Medicus | Life Sciences | pharmacokinetics | bisphenol A | biomonitoring | Review | xenobiotic metabolism | endocrine disruption
Journal Article
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 01/2014, Volume 141, Issue 1, pp. 92 - 116
Drug metabolism | UDP-glucuronosyltransferases | Pharmacogenetics | Pharmacogenetics-based dose adjustments | UGT1A1 | Polymorphism | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | Psychotropic Drugs - pharmacokinetics | Humans | Analgesics - metabolism | Analgesics - pharmacokinetics | Antihypertensive Agents - metabolism | Antihypertensive Agents - pharmacokinetics | Uridine Diphosphate - metabolism | Polymorphism, Genetic | Antineoplastic Agents - metabolism | Glucuronosyltransferase - genetics | Pharmaceutical Preparations - metabolism | Glucuronosyltransferase - metabolism | Anti-HIV Agents - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Psychotropic Drugs - metabolism | Anti-HIV Agents - metabolism | Pharmaceutical Preparations - administration & dosage | Pharmacokinetics | Physiological aspects | Xenobiotics | Index Medicus
Journal Article
Toxicology letters, ISSN 0378-4274, 03/2021, Volume 338, pp. 114 - 127
Uncertainty factor | Chemical risk assessment | Feed additives | Cats | Contaminants | Rats | Pharmacokinetics | Life Sciences & Biomedicine | Toxicology | Science & Technology | Uncertainty | Xenobiotics - administration & dosage | Metabolic Detoxication, Phase II | Risk Assessment | Species Specificity | Food Contamination | Cytochrome P-450 Enzyme System - metabolism | Substrate Specificity | Animal Feed - toxicity | Xenobiotics - toxicity | Xenobiotics - pharmacokinetics | No-Observed-Adverse-Effect Level | Animals | Glucuronosyltransferase - metabolism | Metabolic Detoxication, Phase I | Enzymes | Animal feeding and feeds | Risk assessment | Alfentanil | Physiological aspects | Glycine | Xenobiotics | Index Medicus
Journal Article
Clinical pharmacokinetics, ISSN 0312-5963, 6/2012, Volume 51, Issue 6, pp. 365 - 396
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Pregnancy | Population-pharmacokinetics | Pharmacokinetics | Pharmacokinetic- modelling | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | Inactivation, Metabolic | Body Weight | Glomerular Filtration Rate | Humans | Organ Size | Reference Values | Xenobiotics - pharmacokinetics | Gestational Age | Regional Blood Flow | Algorithms | Pregnancy - metabolism | Models, Biological | Female | Pregnancy - physiology | Databases, Factual | Demographic aspects | Physiological aspects | Reports | Models | Research | Xenobiotics | Health aspects | Index Medicus
Journal Article